查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523169

精准医疗市场报告：2030 年趋势、预测与竞争分析

Precision Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

精准医疗趋势与预测

预计到 2030 年，全球精准医疗市场将达到 1,436 亿美元，2024 年至 2030 年复合年增长率为 9.5%。该市场的主要驱动力是对个人化治疗的需求不断增长以及对伴同性诊断和基因检测的偏好。全球精准医疗市场前景广阔，肿瘤、罕见疾病、感染疾病、血液疾病市场充满机会。

精准医疗按细分领域

本研究按类型、适应症、最终用途和地区对全球精准医疗进行了预测。

精准医疗市场洞察

Lucintel 预计抑制剂在预测期内仍将是最大的细分市场。

在该市场中，肿瘤学预计在预测期内仍将是最大的细分市场。

预计在预测期内，北美仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到2030年，全球精准医疗市场预计将达到1,436亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球精准医疗市场预计将以9.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是对个人化治疗的需求不断增长以及对伴同性诊断和基因检测的偏好。

Q4.市场的主要细分市场是：

A4. 精准医疗市场前景广阔，肿瘤学、罕见疾病、感染疾病和血液学市场充满机会。

Q5.市场的主要企业是：

A5.主要企业如下：

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计抑制剂在预测期内仍将是其最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球精准医疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球精准医疗市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球精准医疗市场
    • 抑制剂
    • 单株抗体
    • 细胞/基因治疗
    • 抗病毒药物/抗逆转录病毒药物
    • 其他的
  • 按适应症分類的全球精准医疗市场
    • 瘤
    • 罕见疾病
    • 感染疾病
    • 血液疾病
    • 其他的
  • 按最终用途分類的全球精准医学市场
    • 医院/诊所
    • 居家医疗

第四章 2018-2030年区域市场趋势及预测分析

  • 全球精准医疗市场区域分布
  • 北美精准医疗市场
  • 欧洲精准医疗市场
  • 亚太精准医疗市场
  • 其他地区精准医疗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球精准医疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球精准医疗市场产能
    • 全球精准医疗市场的併购与合资
    • 认证和许可

第七章主要企业概况

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
简介目录

Precision Medicine Trends and Forecast

The future of the global precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets. The global precision medicine market is expected to reach an estimated $143.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Precision Medicine by Segment

The study includes a forecast for the global precision medicine by type, indication, end use, and region.

Precision Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antiviral & Anti-Retroviral Drugs
  • Others

Precision Medicine Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others

Precision Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Home Care Settings

Precision Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Precision Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision medicine companies profiled in this report include-

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Precision Medicine Market Insights

Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Within this market, oncology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Precision Medicine Market

Market Size Estimates: Precision medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Precision medicine market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Precision medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indications, end uses, and regions for the precision medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the precision medicine market size?

Answer: The global precision medicine market is expected to reach an estimated $143.6 billion by 2030.

Q2. What is the growth forecast for precision medicine market?

Answer: The global precision medicine market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the precision medicine market?

Answer: The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

Q4. What are the major segments for precision medicine market?

Answer: The future of the precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets.

Q5. Who are the key precision medicine market companies?

Answer: Some of the key precision medicine companies are as follows:

  • Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Bristol Myers Squibb
  • AstraZeneca
  • Gilead Sciences
  • AbbVie
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi

Q6. Which precision medicine market segment will be the largest in future?

Answer: Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Q7. In precision medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the precision medicine market by type (inhibitor drugs, monoclonal antibodies, cell & gene therapy, antiviral & anti-retroviral drugs, and others), indication (oncology, rare diseases, infectious diseases, hematological disorders, and others), end use (hospitals & clinics and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Precision Medicine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Precision Medicine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Precision Medicine Market by Type
    • 3.3.1: Inhibitor Drugs
    • 3.3.2: Monoclonal Antibodies
    • 3.3.3: Cell & Gene Therapy
    • 3.3.4: Antiviral & Anti-Retroviral Drugs
    • 3.3.5: Others
  • 3.4: Global Precision Medicine Market by Indication
    • 3.4.1: Oncology
    • 3.4.2: Rare Diseases
    • 3.4.3: Infectious Diseases
    • 3.4.4: Hematological Disorders
    • 3.4.5: Others
  • 3.5: Global Precision Medicine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Home Care Settings

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Precision Medicine Market by Region
  • 4.2: North American Precision Medicine Market
    • 4.2.1: North American Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.2.2: North American Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.3: European Precision Medicine Market
    • 4.3.1: European Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.3.2: European Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.4: APAC Precision Medicine Market
    • 4.4.1: APAC Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.4.2: APAC Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
  • 4.5: ROW Precision Medicine Market
    • 4.5.1: ROW Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
    • 4.5.2: ROW Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Precision Medicine Market by Type
    • 6.1.2: Growth Opportunities for the Global Precision Medicine Market by Indication
    • 6.1.3: Growth Opportunities for the Global Precision Medicine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Precision Medicine Market by Region
  • 6.2: Emerging Trends in the Global Precision Medicine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Precision Medicine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Medicine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Pfizer
  • 7.4: Bristol Myers Squibb
  • 7.5: AstraZeneca
  • 7.6: Gilead Sciences
  • 7.7: AbbVie
  • 7.8: Eli Lilly and Company
  • 7.9: GlaxoSmithKline
  • 7.10: Sanofi